TCT CONNECT-305 Impact of Lesion Location on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Stenosis
David Power(Cardiovascular Institute of the South), Samin K. Sharma(Mount Sinai Health System), Bimmer E. Claessen(Columbia University Irving Medical Center), Samantha Sartori(Icahn School of Medicine at Mount Sinai), Annapoorna Kini(Mount Sinai Medical Center), Roxana Mehran(Mount Sinai Hospital), Adam Reisman(Columbia University Irving Medical Center), Anastasios Roumeliotis(Cardiovascular Institute of the South), George Dangas(Mount Sinai Hospital), Anton Camaj(Columbia University Irving Medical Center), Zhongjie Zhang(Shanxi Medical University), Johny Nicolas(Cardiovascular Institute of the South), Mauro Chiarito(Humanitas University), Ridhima Goel(Cardiovascular Institute of the South), Rishi Chandiramani(Cardiovascular Institute of the South), M. J. R. Healy(American Physical Therapy Association), Davide Cao(Cardiovascular Institute of the South)
Cited by 0
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k